Published in
Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 2(24), p. 177-195, 2022
DOI: 10.1080/14656566.2022.2150966
Links
Tools
Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond
Journal article published in 2022 by
Alberto Bianchi,
Markus von Deimling 
,
Maximilian Pallauf,
Takafumi Yanagisawa,
Tatsushi Kawada,
Hadi Mostafaei,
Fahad Quhal ,
Ekaterina Laukhtina ,
Pawel Rajwa,
Muhammad Majdoub,
Reza Sari Motlagh,
Benjamin Pradere ,
Pierre I. Karakiewicz,
Maria Angela Cerruto,
Alessandro Antonelli
and other authors.
,
Maximilian Pallauf,
Takafumi Yanagisawa,
Tatsushi Kawada,
Hadi Mostafaei,
Fahad Quhal ,
Ekaterina Laukhtina ,
Pawel Rajwa,
Muhammad Majdoub,
Reza Sari Motlagh,
Benjamin Pradere ,
Pierre I. Karakiewicz,
Maria Angela Cerruto,
Alessandro Antonelli
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 